Dr. Angela Stewart -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Angela Stewart, a Internal Medicine physician based in City, LA. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Angela Stewart has received $1,632.77 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

  • Full Name: Dr. Angela Stewart
  • Medical Specialty: Internal Medicine
  • Practice Location: City, LA, Louisiana
  • NPI Number: 1056097600
  • Transparency Score: 50/100
  • Payment Records Span: 2025-04-07 to 2025-04-07

Payment Summary

Dr. Angela Stewart has received a total of $1,632.77 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $1,632.77 per transaction.

  • Total Payments Received: $1,632.77
  • Number of Transactions: 1
  • Average Payment: $1,632.77
  • Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in Internal Medicine. A higher score indicates fewer or more routine payments.
  • Number of Pharma Relationships: 1 pharmaceutical companies
  • Drugs/Devices Referenced: 1 distinct products

Payment Breakdown by Category

The following table shows how Dr. Angela Stewart's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription

The largest payment category for Dr. Angela Stewart is Speaking & Education, accounting for 0% ($0.00) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Angela Stewart. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Vertex Pharmaceuticals$1,632.771

Dr. Angela Stewart has a financial relationship with Vertex Pharmaceuticals, receiving $1,632.77 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

Drugs and Medical Devices Referenced in Payments

The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Angela Stewart. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.

  • Ozempic -- Referenced in payment records from pharmaceutical companies to Dr. Angela Stewart

The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Angela Stewart's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Angela Stewart has received $1.6K across 1 pharmaceutical payments as a Internal Medicine physician in City, LA. Top paying companies include Vertex Pharmaceuticals ($1.6K). Dr. Angela Stewart received a single payment of $1633 from Vertex Pharmaceuticals in 2025, representing 100% of her total pharmaceutical payments. The payment was for the drug Ozempic and occurred in 2025.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Angela Stewart is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consumers should be aware that Dr. Stewart receives all her pharmaceutical payments from Vertex Pharmaceuticals for Ozempic, which may indicate a strong relationship with this company. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Angela Stewart Compares to Other Internal Medicine Physicians

Compared to peers in Internal Medicine, Dr. Stewart's payment profile is relatively transparent but shows a high concentration in payments from a single company.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Angela Stewart in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Vertex Pharmaceuticals$1,632.77generalOzempic2025-04-07Not Assessed

Frequently Asked Questions About Dr. Angela Stewart's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Angela Stewart received?

Angela Stewart has received a total of $1.6K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Angela Stewart taking too much pharma money?

Angela Stewart has received $1.6K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Internal Medicine), the types of payments, and how they compare to peers. The largest payment category is general ($1.6K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Angela Stewart?

The top pharmaceutical companies paying Angela Stewart are: Vertex Pharmaceuticals ($1.6K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Angela Stewart receive?

Angela Stewart's payments by type: general: $1.6K.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Angela Stewart's payments compare to other Internal Medicine doctors?

To compare, look at the total amount ($1.6K), number of payments (1), and the types of payments received. Internal Medicine physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Angela Stewart's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1056097600). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Angela Stewart's pharma payment profile?

Dr. Stewart has a 100% concentration in payments from a single company, Vertex Pharmaceuticals. Angela Stewart has received $1.6K in total pharma payments.

How does Angela Stewart compare to peers in Internal Medicine?

Compared to peers in Internal Medicine, Dr. Stewart's payment profile is relatively transparent but shows a high concentration in payments from a single company.

Are Angela Stewart's pharma relationships typical for Internal Medicine?

The payment was for a single drug, Ozempic, indicating a high concentration in a specific medication.

What should patients of Angela Stewart know about these payments?

Consumers should be aware that Dr. Stewart receives all her pharmaceutical payments from Vertex Pharmaceuticals for Ozempic, which may indicate a strong relationship with this company.

What patterns are visible in Angela Stewart's payment history?

There is no yearly trend data available beyond the single payment in 2025.

Understanding This Doctor Payment Report

This transparency report for Dr. Angela Stewart is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

  • Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
  • Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
  • Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. Internal Medicine physicians may have very different payment norms than physicians in other fields.
  • Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
  • Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Angela Stewart's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Angela Stewart and all other physicians can be accessed at the official CMS Open Payments website.

Other Internal Medicine Physicians

Compare Dr. Angela Stewart's pharmaceutical payments with other Internal Medicine physicians ranked by total pharma payments received.

PhysicianStateTotal Payments
Karen HarrisAL$373,560.30
Andrew YoungMN$373,004.12
Catherine MorrisMI$329,087.36
Benjamin CookAL$290,577.64
Patricia DavisIN$229,890.74
Karen HarrisPA$223,458.75
Charles BakerOH$174,454.86
Amanda LewisTN$161,516.05
Amanda LewisAL$145,697.34
Christine EdwardsTX$144,283.94

Top Doctors in Louisiana

These physicians in Louisiana have received the highest pharmaceutical payments. See how Dr. Angela Stewart compares to peers in the same state.

PhysicianSpecialtyTotal Payments
Stephanie KingNeurology$308,624.53
Timothy RogersDermatology$300,324.91
Charles BakerCardiology$189,146.74
Amanda LewisPsychiatry$186,870.46
Jeffrey CampbellNeurology$174,169.56
Brian WrightOncology$163,512.80
Laura HallHematology$146,752.97
Michelle ScottOncology$135,372.63
David KimOncology$132,860.92
David KimGenetics$130,702.83

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.